FDA to Study Hydroxychloroquine for COVID-19 |
Clinical News
eMediNexus Coverage from: 
FDA to Study Hydroxychloroquine for COVID-19

1 Read Comments                

The FDA is considering hydroxychloroquine, the malaria and rheumatology drug, as a treatment for COVID-19, said FDA Commissioner Stephen Hahn.Hydroxychloroquine is one of the several drugs already approved for other indications that the president wants the FDA to look at as possible treatment option for COVID-19, Hahn said at a White House coronavirus task force briefing. "We want to do that in the setting of a clinical trial -- a large, pragmatic clinical trial -- to actually gather that information and answer the question that needs to be asked and answered." (Medpage Today)...
To Read or comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now